Sep 24

Voro Therapeutics Announces Research Collaboration to Advance Conditionally Activated Biologics for Immunology and Inflammation

Jun 18

Voro Therapeutics and Alloy Therapeutics Enter Strategic Research Collaboration to Advance Next-Generation Masked T-Cell Engager Therapeutics

Apr 1

Voro Therapeutics to Present New Preclinical Data on PrimeBody™ Platform and VOR-101 at Upcoming AACR 2026 and AET Europe Conferences

12